561 results on '"Migliorini, Angela"'
Search Results
2. Long-Term Durability of Transcatheter Aortic Valve Implantation With Self-Expandable Valve System (from a Real-World Registry)
3. Long-Term Mortality Comparison of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Culprit-Only or Multivessel Percutaneous Coronary Intervention
4. The Value of a Coronary Computed Tomography Angiography plus Stress Cardiac Magnetic Resonance Imaging Strategy for the Evaluation of Patients with Chronic Coronary Syndrome
5. On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty
6. Relationship between CHA2DS2-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome
7. APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practice
8. Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial
9. Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D) Lesions
10. A New Risk Score to Predict Long-Term Cardiac Mortality in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Primary Percutaneous Intervention
11. Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI
12. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity
13. High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI
14. Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus
15. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)
16. Impact on Left Ventricular Function and Remodeling and on 1-Year Outcome in Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
17. Chronic total occlusion revascularization: A complex piece to 'complete' the puzzle
18. Impact of Chronic Total Occlusion Revascularization in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
19. 642 VALUE OF CORONARY CTA TO RULE OUT OBSTRUCTIVE CORONARY ARTERY DISEASE IN HIGH-RISK PATIENTS CANDIDATES FOR TAVI
20. 554 HYPERLIPOPROTEIN(A) AND PREMATURE CORONARY ARTERY DISEASE: A CALL FOR ACTION
21. Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary intervention
22. Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: The Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study
23. Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty
24. Smoking and infarct size among STEMI patients undergoing primary angioplasty
25. Subacute Stent Thrombosis Related to Kounis Syndrome During Anaphylaxis Induced by Ultrasound Contrast Agent Infusion
26. Comparison of myocardial reperfusion between intracoronary versus intravenous cangrelor administration in patients undergoing primary percutaneous coronary intervention.
27. Percutaneous Coronary Intervention for Multiple Chronic Total Occlusions
28. Comparison of the Degree of Platelet Aggregation Inhibition With Prasugrel Versus Clopidogrel and Clinical Outcomes in Patients With Unprotected Left Main Disease Treated With Everolimus-Eluting Stents
29. Time-to-treatment and infarct size in STEMI patients undergoing primary angioplasty
30. Prognostic Value of Myocardial Injury Following Transcatheter Aortic Valve Implantation
31. Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
32. Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty
33. Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study
34. Prognostic value of reverse left ventricular remodeling after primary angioplasty for STEMI
35. Residual Platelet Reactivity, Bleedings, and Adherence to Treatment in Patients Having Coronary Stent Implantation Treated With Prasugrel
36. Outcomes of Left Main Revascularization after Percutaneous Intervention or Bypass Surgery
37. Comparison of Everolimus-Eluting Stent With Paclitaxel-Eluting Stent in Long Chronic Total Occlusions
38. Switching from clopidogrel to prasugrel in patients having coronary stent implantation
39. Effects of a timely therapy with doxycycline on the left ventricular remodeling according to the pre-procedural TIMI flow grade in patients with ST-elevation acute myocardial infarction
40. Preprocedural TIMI flow and infarct size in STEMI undergoing primary angioplasty
41. Rheolityc Thrombectomy in Acute Myocardial Infarction: Effect on Microvascular Obstruction, Infarct Size, and Left Ventricular Remodeling
42. Heart rate as an independent prognostic risk factor in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
43. Evaluation of the influence of age and gender on the relationships between infarct size, infarct severity, and left ventricular ejection fraction in patients successfully treated with primary percutaneous coronary intervention
44. Usefulness of Primary Angioplasty in Nonagenarians With Acute Myocardial Infarction
45. Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)
46. “Tailored” antiplatelet bridging therapy with cangrelor: moving toward personalized medicine
47. Variable underlying morphology of culprit plaques associated with ST-elevation myocardial infarction: an optical coherence tomography analysis from the SMART trial
48. Effect of diabetes on scintigraphic infarct size in STEMI patients undergoing primary angioplasty
49. Comparison of Effects of Primary Coronary Angioplasty on Left Ventricular Remodeling and Heart Failure in Patients
50. Effectiveness of Primary Percutaneous Coronary Interventions for Stent Thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.